CATALOGO DEI PRODOTTI DELLA RICERCA

ZANOTTI, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.453
NA - Nord America 4.024
AS - Asia 2.754
SA - Sud America 338
AF - Africa 38
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.626
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.967
RU - Federazione Russa 1.644
CN - Cina 1.134
GB - Regno Unito 1.081
SG - Singapore 985
SE - Svezia 344
IT - Italia 273
BR - Brasile 263
DE - Germania 254
HK - Hong Kong 228
FR - Francia 225
IE - Irlanda 203
FI - Finlandia 191
VN - Vietnam 173
UA - Ucraina 50
NL - Olanda 45
KR - Corea 41
CA - Canada 35
BE - Belgio 33
IN - India 31
JP - Giappone 29
TR - Turchia 28
AR - Argentina 27
PL - Polonia 25
ID - Indonesia 23
BD - Bangladesh 20
AT - Austria 18
ES - Italia 16
MX - Messico 16
ZA - Sudafrica 14
AU - Australia 13
EC - Ecuador 11
UZ - Uzbekistan 10
CL - Cile 9
CO - Colombia 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
IQ - Iraq 6
IR - Iran 6
MA - Marocco 6
VE - Venezuela 6
BO - Bolivia 5
DK - Danimarca 5
LT - Lituania 5
PE - Perù 5
PK - Pakistan 5
AZ - Azerbaigian 4
GR - Grecia 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
RO - Romania 4
BJ - Benin 3
DZ - Algeria 3
HR - Croazia 3
LV - Lettonia 3
PT - Portogallo 3
PY - Paraguay 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CG - Congo 2
CR - Costa Rica 2
EU - Europa 2
HU - Ungheria 2
JO - Giordania 2
LK - Sri Lanka 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
RS - Serbia 2
SI - Slovenia 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
KH - Cambogia 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
NG - Nigeria 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
SN - Senegal 1
TG - Togo 1
TM - Turkmenistan 1
Totale 11.626
Salva come PNG Salva come JPEG
Città #
Southend 928
Moscow 570
Chandler 511
Singapore 468
Dallas 397
Jacksonville 320
Ashburn 316
Woodbridge 304
Ann Arbor 293
Beijing 281
Hong Kong 227
Dublin 201
Houston 160
New York 125
Wilmington 106
Jinan 88
Lawrence 80
Princeton 80
Los Angeles 72
The Dalles 71
Nanjing 65
Munich 58
Shenyang 55
Ho Chi Minh City 54
Helsinki 49
Verona 49
Bologna 39
Hebei 39
Hanoi 37
Tianjin 37
Columbus 36
Ningbo 34
Brussels 33
São Paulo 32
Buffalo 31
Zhengzhou 30
Changsha 29
Hangzhou 29
Taizhou 29
Haikou 28
Boardman 27
Guangzhou 26
Redondo Beach 26
Tokyo 26
Turku 24
Denver 22
Chicago 21
Groningen 21
Milan 21
Nanchang 21
Sindelfingen 21
Santa Clara 20
Warsaw 20
Manchester 19
Seattle 18
Jiaxing 17
Norwalk 17
Taiyuan 16
Dearborn 15
Redwood City 15
Seoul 15
Chennai 14
Vienna 14
Atlanta 13
Falls Church 13
Montreal 13
Stockholm 13
Lancaster 12
Boston 11
Brooklyn 11
Dong Ket 11
Falkenstein 11
San Francisco 11
Fuzhou 10
Jakarta 10
Johannesburg 10
Lanzhou 10
Phoenix 10
Tashkent 10
Amsterdam 9
Frankfurt am Main 9
London 9
Orem 9
Poplar 9
Rome 9
Augusta 8
Belo Horizonte 8
Düsseldorf 8
Fairfield 8
Haiphong 8
Mexico City 8
Redmond 8
Rio de Janeiro 8
Toronto 8
Washington 8
Ardabil 6
Biên Hòa 6
New Delhi 6
Nuremberg 6
Riva 6
Totale 7.190
Salva come PNG Salva come JPEG
Nome #
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 299
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 229
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 228
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 222
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 219
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 217
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 201
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 200
BCR-signaling profiles associated with prognosis and progression in B-CLL 199
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 199
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 195
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 194
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 190
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 186
BCR-signaling profiles associated with prognosis and progression in B-CLL 184
Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected 184
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 182
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 180
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 177
A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions 177
Bone involvement and osteoporosis in mastocytosis. 176
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 174
Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis. 174
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 171
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis 170
Bone involvement in patient with clonal mast cell disorders 164
The high oxygen affinity haemoglobin Nantes: a family case description 163
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 162
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network 162
Improved detection of the C-KIT D816V mutation using allele-specific arms real time PCR assay allows a finer recognition of patients with indolent systemic mastocytosis. 156
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 154
Flow cytometry analysis of B-cell receptor phospho-protein networks in chronic lymphocytic leukemia 149
Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders 147
Underdiagnosed systemic mastocytosis: The role of flow cytometry 147
Bone Disease in Mastocytosis 147
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma 147
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 146
Effects of denosumab on peripheral lymphocyte subpopulations 145
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis 144
Prevalence of osteoporosis in patients affected by mastocytosis 142
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 139
GREY ZONES OF HODGKIN LYMPHOMA: REPORT OF A CASE WITH FEATURES INTERMEDIATE BETWEEN PRIMARY MEDIASTINAL B-CELL LYMPHOMA, CLASSICAL HODGKIN LYMPHOMA AND NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA 139
Systemic mastocytosis: a muldisciplinary approach (Review) [Lamastocitosi sistemica: Un approccio multidiscliplinare] 136
Vaccination Management In Children and Adults With Mastocytosis 136
Osteopetrosi 135
Ultra-deep sequencing (UDS) allows more sensitive detection of the D816V and other KIT gene mutations in systemic mastocytosis 133
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 130
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 130
Serum tryptase levels differently change over time in indolent systemic mastocytosis with or without skin lesions. 128
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients 127
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 123
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry 123
Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms 122
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 121
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation 121
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 118
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 115
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification 115
Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association 114
Skeletal implications of isolated bone marrow mastocytosis (reply): Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis (reply) 113
Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission 110
Rapid skeletal turnover in radiographic mimic of osteopetrosis might be secondary to systemic mastocytosis [corrected] 110
Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case series 110
Single Cell Network Profiling (SCNP) assay reveals B Cell Receptor Signaling heterogeneity in the Context of ZAP-70 Expression in patients with Chronic Lymphocytic Leukemia (CLL) 109
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia 109
Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis 104
Mastocytosis and allergic diseases 103
Mast Cell Disorders In Drug Hypersensitivity 101
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study 100
Mastocytosis and insect venom allergy 94
Serum levels of bone cytokines in indolent systemic mastocytosis associated with osteopenia or osteoporosis. 92
Systemic Mastocytosis 92
Hymenoptera Allergy and Mast Cell Activation Syndromes 92
Male osteoporosis and hymenoptera venom anaphylaxis [Osteoporosi maschile e anafilassi da imenotteri] 90
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders 83
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM 78
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives 75
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis 65
Occupational exposure to glyphosate and risk of lymphoma:results of an Italian multicenter case-control study 61
Night shift work and lymphoma: results from an Italian multicentre case-control study 58
Letter to the Editor: Rapid Skeletal Turnover in a Radiographic Mimic of Osteopetrosis Might Be Secondary to Systemic Mastocytosis 51
null 44
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis 38
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis 15
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted 12
Occupational exposure to formaldehyde and risk of lymphoma subtypes: results of a multicentre Italian case-control study 10
Totale 11.726
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.309
article - articoli 26.094
book - libri 0
conference - conferenze 11.215
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.618
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021352 0 0 0 0 0 79 14 30 26 10 156 37
2021/2022744 55 237 8 91 42 19 21 42 35 22 39 133
2022/20231.442 92 170 114 292 92 362 30 76 163 10 26 15
2023/2024773 57 66 47 69 88 132 37 71 5 39 123 39
2024/20251.771 85 126 98 300 80 47 78 62 287 124 160 324
2025/20263.556 379 301 405 897 1.362 212 0 0 0 0 0 0
Totale 11.726